UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

Oxidative medicine and cellular longevity, 2019-01, Vol.2019 (2019), p.1-18

2019

Volltextzugriff (PDF)

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus

PLoS pathogens, 2019-02, Vol.15 (2), p.e1007375-e1007375

2019

Volltextzugriff (PDF)

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis

Experimental and Molecular Medicine, 2023, 55(0), , pp.2346-2356

2023

Volltextzugriff (PDF)

FDF-based combustion instability analysis for stabilization effects of a slotted plate in a multiple flame combustor

Aerospace science and technology, 2017-11, Vol.70, p.95-107

2017

Volltextzugriff (PDF)

Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination

Clinical infectious diseases, 2022-12, Vol.75 (12), p.2243-2246

2022

Volltextzugriff (PDF)

Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination

Clinical infectious diseases, 2022-06

2022

Volltextzugriff (PDF)

Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction

Angewandte Chemie International Edition, 2024-11, Vol.63 (47), p.e202405472-n/a

International ed. in English, 2024

Volltextzugriff (PDF)

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody

International journal of molecular sciences, 2019-10, Vol.20 (20), p.5073

2019

Volltextzugriff (PDF)

Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation

Antiviral research, 2022-12, Vol.208, p.105428-105428, Article 105428

2022

Volltextzugriff (PDF)

Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibit the infection of SARS-CoV-2 variants and syncytium formation

Antiviral research, 2022-10

2022

Volltextzugriff (PDF)

Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody

Biochemical and biophysical research communications, 2021-03, Vol.545, p.33-39

2021

Volltextzugriff (PDF)

Celecoxib is the only nonsteroidal anti-inflammatory drug to inhibit bone progression in spondyloarthritis

BMB Reports, 2024-09

2024

Volltextzugriff (PDF)

Mechanical and Biocompatibility Properties of Sintered Titanium Powder for Mimetic 3D-Printed Bone Scaffolds

ACS omega, 2022-03, Vol.7 (12), p.10340-10346

2022

Volltextzugriff (PDF)

Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without

The Journal of infection, 2022-01, Vol.84 (1), p.94-118

2022

Volltextzugriff (PDF)

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers

The Journal of infection, 2022-12, Vol.85 (6), p.e177-e180

2022

Volltextzugriff (PDF)

Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay

Antiviral research, 2023-01, Vol.209, p.105473, Article 105473

2023

Volltextzugriff (PDF)

Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors

Bioorganic & medicinal chemistry letters, 2019-12, Vol.29 (23), p.126727-126727, Article 126727

2019

Volltextzugriff (PDF)

The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Viruses, 2020-03, Vol.12 (3), p.302

2020

Volltextzugriff (PDF)

Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction

Angewandte Chemie, 2024-11, Vol.136 (47), p.n/a

2024

Volltextzugriff (PDF)

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS597-TPS597

2020

Volltextzugriff (PDF)

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane

Cancer chemotherapy and pharmacology, 2014-10, Vol.74 (4), p.799-808

2014

Volltextzugriff (PDF)

Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma

Journal of neuro-oncology, 2014-10, Vol.120 (1), p.199-207

2014

Volltextzugriff (PDF)

Randomized phase II trial comparing 4 doublets as a front-line treatment in Asian patients with recurrent/metastatic gastric cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4063-4063

2016

Volltextzugriff (PDF)

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations

Cancer Research and Treatment, 2022, 54(1), , pp.30-39

2022

Volltextzugriff (PDF)

Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic

Science advances, 2024-03, Vol.10 (9), p.eadk6425

2024

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(33)

Sprache

Englisch
(30)
Koreanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MHY2233 Attenuates Replicative Cellular Senescence in Human Endothelial Progenitor Cells via SIRT1 Signaling

An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis

FDF-based combustion instability analysis for stabilization effects of a slotted plate in a multiple flame combustor

Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination

Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination

Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody

Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibits the infection of SARS-CoV-2 variants and syncytium formation

Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibit the infection of SARS-CoV-2 variants and syncytium formation

Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody

Celecoxib is the only nonsteroidal anti-inflammatory drug to inhibit bone progression in spondyloarthritis

Mechanical and Biocompatibility Properties of Sintered Titanium Powder for Mimetic 3D-Printed Bone Scaffolds

Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers

Rapid discovery and classification of inhibitors of coronavirus infection by pseudovirus screen and amplified luminescence proximity homogeneous assay

Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors

The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer (TNBC) with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane

Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma

Randomized phase II trial comparing 4 doublets as a front-line treatment in Asian patients with recurrent/metastatic gastric cancer

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations

Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic

Suchergebnisse filtern